Green light-emitting diode phototherapy for neonatal hyperbilirubinemia: Randomized controlled trial
Pediatrics International May 26, 2019
Kuboi T, et al. - In patients with neonatal hyperbilirubinemia, researchers compared the effectiveness of green light-emitting diode (LED) phototherapy and blue LED phototherapy. They randomly allocated hyperbilirubinemia neonates to a group of green LED or blue LED phototherapy. Both groups had 24 h phototherapy, and before and after 24 h phototherapy, blood was sampled. Enzymatic methods were used to measure total serum bilirubin (TSB), and high-performance liquid chromatography was used to measure bilirubin photoisomers. For this prospective randomized controlled trial, 34 infants (green, n = 16; blue, n = 18) were randomized. There was no significant difference between the groups in reduction of TSB after phototherapy. According to findings, both light sources significantly reduced TSB, indicating clinical efficacy.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries